Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimize treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount of useful data obtained. However, NGS has had only a limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyze NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
healthcare, NGS genomic data, genomic medicine
Between €2.5 million-5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as SeqOne? We’re happy to assist you with our Startup Sourcing service.